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Abstract 
The mechanism of store-operated Ca2+ inflow in hepatocytes was investigated using fluo-3 and fura-2 to monitor changes in the concentration 
of intracellular free Ca 2÷ in single cells, and 1-(¢t-glycerophosphoryl)-myo-inositol 4,5-diphosphate, p~5). 1-(2-nitrophenyl)ethyl ester ('caged' GPIP2) 
and 'caged' guanosine 5'-[ythio]triphosphate (GTPTS) (introduced into the cytoplasmic space by microinjection), thapsigargin and 2,5-di-tert- 
butylhydroqninone (DBHQ) to stimulate Ca 2+ inflow. Photolysis of 'caged' GPIP2 or 'caged' GTPTS stimulated Ca 2÷ inflow. The abilities of GPIP2, 
thapsigargin and DBHQ to stimulate Ca 2+ inflow were inhibited by the pre-treatment of hepatocytes with pertussis toxin in vivo for 36 h. 
Thapsigargin-stimulated Ca 2÷ inflow was also inhibited by guanosine 5'-[B-thio]diphosphate (GDPflS) (introduced by microinjection). It is concluded 
that, in hepatocytes, store-operated Ca 2÷ inflow induced by the actions of either inositol 1,4,5-trisphosphate, hapsigargin or DBHQ requires a 
pertussis toxin-sensitive trimeric G-protein. 
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1. Introduction 
Receptor -act ivated Ca 2÷ inflow across the plasma 
membrane of hepatocytes and other animal cells plays an 
essential role in the processes by which extracellular sig- 
nals induce physiological responses [1-4]. The stimula- 
tion of Ca 2÷ inflow by an agonist-receptor complex ap- 
pears to be a consequence of the depletion of Ca 2+ pres- 
ent in inositol 1,4,5-trisphosphate (InsP3)-sensitive stores 
[5-9] such that an increase in InsP3 is a prerequisite for 
the stimulation of Ca 2+ inflow. Thus, in hepatocytes and 
many types of animal cells the depletion of Ca 2÷ in intra- 
cellular stores, induced by agonists, thapsigargin and 
some other agents, has been shown to mimic the action 
of extracellular signals in stimulating Ca 2÷ inflow [8-11]. 
It has not yet been established conclusively whether this 
store-operated [12] Ca 2÷ inflow is part of the physiologi- 
cal actions of extracellular signals in stimulating Ca 2÷ 
inflow. Moreover, the molecular events in store-operated 
Ca 2÷ inflow have not been elucidated, although they may 
involve a mobile intracellular messenger [13-16]. 
It has previously been shown that, in hepatocytes, 
GTPTS (introduced by a cell permeation technique or by 
microinjection) mimics the ability of vasopressin to stim- 
ulate Ca 2÷ inflow [17,18]. Moreover, the treatment of 
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hepatocytes with pertussis toxin in vivo for 24-72 h in- 
hibits vasopressin-and GTPyS-stimulated Ca z÷ inflow 
but not the release of Ca 2+ from intracellular stores in- 
duced by these agents [18-20]. Inhibition of vasopressin- 
stimulated Ca 2+ inflow was not observed when hepato- 
cytes were exposed to pertussis toxin for 1 h following 
microinjection of the toxin to the cells [18]. These results 
have led to the conclusion that the actions of a slowly- 
ADP-ribosylated trimeric GTP-binding protein (G-pro- 
tein) are required in the mechanism by which vasopressin 
stimulates Ca 2+ inflow [18-20] (but see [21]). 
The aims of the present experiments were two-fold. 
Firstly to conduct a more direct test of the abilities 
of intracellular InsP3 and GTPTrS to stimulate Ca 2+ in- 
flow by determining whether Ca z÷ inflow can be stimu- 
lated by the photolysis of 1-(ot-glycerophosphoryl)-myo- 
inositol 4,5-diphosphate, P4(5)-l-(2-nitrophenyl)ethyl 
ester ('caged' GPIP2) or 'caged' guanosine 5'-[7- 
thio]triphosphate (GTPyS). Secondly to determine 
whether a pertussis toxin-sensitive G-protein is required 
when Ca 2+ inflow is stimulated by the depletion of Ca 2÷ 
in intracellular stores, induced by InsP3, thapsigargin or 
2,5-di-tert-butylhydroquinone (DBHQ) (i.e. required for 
store-operated Ca2+ inflow). We show here, using single 
hepatocytes and the technique of microinjection, that 
intracellular InsP3 and GTPyS stimulate Ca 2÷ inflow. 
Moreover, the results indicate that a trimeric G-protein, 
sensitive to pertussis toxin, is required for store-operated 
Ca 2+ inflow when this is initiated by InsP3, thapsigargin 
or DBHQ. The results provide further evidence which 
indicates that the process of store-operated Ca 2+ inflow 
is a component of the physiological pathway by which 
agonists timulate Ca 2÷ inflow in hepatocytes, and point 
All rights reserved. 
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to a central function for a trimeric G-protein in this 
process. 
2. Materials and methods 
2.1. Materials 
Fluo-3, fura-2 and 'caged' GTPyS were obtained from Molecular 
Probes, Eugene, OR, USA; 'caged' GPIP2 and adenosine 5'-[B- 
thio]diphosphate from Calbiochem-Novabiochem, Alexandria, NSW, 
Australia; and thapsigargin, DBHQ and pertussis toxin from Sigma- 
Aldrich, Castle Hill, NSW, Australia. All other chemicals were ob- 
tained from the sources described previously [18]. 
2.2. Methods 
Hepatocytes were isolated, attached to coverslips coated with colla- 
gen, and fluo-3 (10 mM in the pipette tip), fura-2 (10 mM in the pipette 
tip), 'caged' GPIP2 (24 mM in the pipette tip), 'caged' GTPyS (30 mM 
in the pipette tip), GDPflS (90 mM in the pipette tip), ADPflS (90 mM 
in the pipette tip) and GMP (90 mM in the pipette tip) were introduced 
to the cytoplasmic space by microinjection, as described previously [18]. 
In order to estimate the degree of dilution of nucleotides and other 
agents injected into hepatocytes, the fluorescence of cells loaded with 
fluo-3 by microinjection and incubated at saturating [Ca2+]i was com- 
pared with the fluorescence ofmicrodroplets (with a similar volume to 
that of hepatocytes) formed by the microinjection of Ca2÷-saturated 
fluo-3 into silicon oil. The dilution factor for the microinjection of 
agents to hepatocytes was found to be 50-100 fold. Thus the concentra- 
tions of GDPflS and 'caged' GTPyS in the cytoplasmic space of hepa- 
tocytes were estimated to be 0.9-1.8 mM and 0.3-0.5 mM, respectively. 
Pertussis toxin (25/tg/100 g body weight) was administered to rats 
by intraperitoneal injection 36 h before isolation of the hepatocytes. 
Ca 2+ inflow to single hepatocytes was monitored by measuring the 
increase in fluorescence of intracellular fluo-3 or fura-2 following the 
addition of extracellular Ca 2+ (Ca2o ÷) to bepatocytes incubated in the 
absence of added CaZo +, as described previously [18]. Mn 2+ inflow was 
measured in cells loaded with fura-2 by microinjection, using a modifi- 
cation of the methods described previously [22]. 
Fluorescence was measured using an inverted TMD-EF fluorescence 
microscope, a photometer (Nikon Corporation, Tokyo, Japan) and the 
UMANS filter changing and data recording system, as described previ- 
ously [18]. The excitation light source was a mercury lamp. Conditions 
for the excitation of fura-2 and the measurement of fura-2 fluorescence 
were as described previously [18]. For experiments involving 'caged' 
compounds, fluo-3 was employed for the measurement of intracellular 
free Ca 2+ concentrations ([CaZ÷].0 [23]. Excitation of fluo-3 was at 490 
nm and a Nikon barrier filter B (wavelength 520 rim) was employed to 
isolate mitted light. Photolysis of'caged' compounds was achieved by 
exposing the cell to the full spectrum of light from the mercury lamp 
for 3-5 s while the shutter to the photometer was closed. 
3. Results 
3.1. Activation of Ca 2+ inflow by photolysis of 'caged' 
GPIPe and 'caged" GTPTS 
To investigate whether InsP3 can activate Ca 2+ inflow 
across the plasma membrane of  hepatocytes, 'caged' 
GPIP2, which yields a slowly-hydrolysable form of  InsP3 
upon photolysis [24], was introduced to hepatocytes by 
microinjection together with fluo-3. Fig. la  (thick solid 
line) shows that, in a single hepatocyte incubated initially 
in the absence of  added Ca2o +, the photolysis of  'caged' 
GPIP2 induced a rapid transient increase in fluorescence 
due to the InsP3-induced release of  Ca z+ from intracellu- 
lar stores [24]. Addit ion of  Ca2o + induced a further increase 
in fluorescence resulting f rom Ca 2+ inflow across the 
L.A. Berven, G.J. Barritt/FEBS Letters 346 (1994) 235-240 
plasma membrane [1 I, 18]. No  substantial increase in flu- 
orescence was observed following the addition of Ca2o ÷ to 
hepatocytes treated with 'caged' GPIP2 but not exposed 
to UV light (Fig. la, broken line). In cells loaded only 
with fluo-3, exposure to UV light caused a small increase 
in fluorescence which, in most cases, occurred 1-2 min 
after UV exposure (Fig. la, thin solid line). These cells 
showed no significant increase in fluorescence following 
the addition of  Ca2o +. 
The ability of  GPIP2 to stimulate divalent cation in- 
flow was confirmed using Mn 2÷ [21,22]. Thus in cells 
loaded with 'caged' GPIP2 and fluo-3, photolysis led to 
a stimulation of  Mn 2+ inflow, assessed by the quenching 
of  fluo-3 (results not shown). 
In cells loaded with 'caged' GTPzS,  photolysis of  this 
'caged' compound also stimulated Ca :÷ inflow (Fig. lb, 
solid line). In control cells loaded with 'caged' GTPzS  
but not exposed to UV light little Ca 2+ inflow was ob- 
served following the addition of  Ca2o + (Fig. lb, broken 
line). 
3.2. Effects of pertussis toxin and GDP~S on GPIP2-, 
thapsigargin- and DBHQ-stimulated Ca e+ inflow 
The ability of  'caged' GP IP  2 to stimulate Ca 2÷ inflow 
was almost completely inhibited in hepatocytes i olated 
f rom rats treated with pertussis toxin (Fig. 2a). The toxin 
had no observable ffect on the amount  of  Ca 2+ released 
f rom intracellular stores. Treatment with pertussis toxin 
also blocked thapsigargin-stimulated Ca 2÷ inflow to 
hepatocytes without altering the ability of  thapsigargin 
to release Ca 2÷ from intracellular stores (Fig. 2b). A 
similar inhibition by pertussis toxin was observed when 
DBHQ (25/.tM in the extracellular medium) was used in 
place of  thapsigargin (9 out of  9 cells tested, results not 
shown). These observations suggest that a pertussis 
toxin-sensitive trimeric G-protein is required in the proc- 
ess by which thapsigargin and DBHQ stimulate Ca 2+ 
inflow. This idea was tested further using guanosine 
5'-[fl-thio]diphosphate (GDPflS), an inhibitor of  the ac- 
tion of  trimeric G-proteins [25]. Introduction of GDPflS 
to the cytoplasmic space of  hepatocytes by microinjec- 
tion inhibited by more than 50% thapsigargin-stimulated 
Ca z÷ inflow but had no observable ffect on the ability 
of  thapsigargin to release Ca 2+ from intracellular stores 
(Fig. 3). When GMP was employed in place of  GDPflS 
there was no inhibition of  thapsigargin-stimulated Ca 2+ 
inflow (Fig. 3). Attempts were made to use ADPflS in 
place of  GDPflS. However, the results suggested that 
ADPflS inhibits Ca 2÷ efflux f rom the cytoplasmic space 
which precluded the use of ADPflS as a control. 
4. Discussion 
Upon photolysis, 'caged' GP IP  2 liberates GPIP2, a 
slowly-hydrolysable analogue of  InsP3 [24]. Thus the ob- 
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Fig. 1. The stimulation of Ca 2+ inflow by GPIP2 and GTPTS. The thick solid line is a representative trace obtained from a single hepatocyte loaded 
with fluo-3 and 'caged' GPIP2 (a) or 'caged' GTP~,S (GTP[S]) Co), incubated initially in the absence of added Ca 2+ then exposed to UV light (arrow) 
and 1.3 mM Ca2+o (added at the beginning of the period indicated by the horizontal bar). The results hown are those obtained for 15 of 22 cells 
tested and 8 of 14 cells tested for (a) and (b), respectively. The broken lines in (a) and (b) show control experiments in which the cells were not exposed 
to UV light to photolyse the 'caged' compound before the addition of Ca 2+. For each of (a) and (b), 4 cells were tested in the control experiment. 
Each gave a trace similar to the one shown. The thin solid line in (a) represents an experiment i  which cells injected with fluo-3 (in the absence of 
GPIP2 or GTPyS) were exposed to UV and then to Ca 2+. Traces imilar to the thin solid line were obtained with each of eight cells tested. 
servation that the photolysis of 'caged' GPIP2 stimulates 
Ca 2+ inflow provides further evidence for the idea [11,18] 
that an increase in InsPa is a necessary step in the mech- 
anism by which vasopressin and other G-protein-cou- 
pled receptors timulate plasma membrane Ca 2÷ inflow 
in hepatocytes. While the results of previous experiments 
have suggested a role for InsP3 in this process [11,18], the 
use of a 'caged' analogue of InsP3 has allowed a more 
direct test of the proposal. 
As in the case of the generation of GPIP2 from 'caged' 
GPIP2, the results obtained with 'caged' GTPyS provide 
more direct evidence that intracellular GTPyS can stim- 
ulate Ca 2÷ inflow. The photolysis of 'caged' GTP?'S, 
which generates a slowly-hydrolysable analogue of GTP, 
would be expected to activate all trimeric G-proteins in 
the hepatocyte [26]. These include Gq/11, the activator of 
phospholipase Cfl. This enzyme catalyses the formation 
of InsP3 when this is induced by vasopressin and other 
G-protein-coupled receptors [27]. In the present experi- 
ments, the ability of GTPyS to stimulate Ca 2÷ inflow is 
likely to be due to the generation of InsP3, through the 
activation of phospholipase Cfl, and also to the activa- 
tion of any other trimeric G-proteins which may lie on 
the pathway between the receptor and the putative 
plasma membrane Ca 2÷ channel. 
The results obtained with pertussis toxin indicate that 
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the process by which InsP3, thapsigargin and DBHQ 
induce plasma membrane Ca z÷ inflow (i.e. store-oper- 
ated Ca 2+ inflow) requires apertussis toxin-sensitive pro- 
tein. The most likely candidate for this protein is a 
trimeric G-protein [26]. Previous experiments have 
shown that the inability of vasopressin to stimulate Ca 2÷ 
inflow in hepatocytes treated with pertussis toxin in vivo 
is unlikely to be due to general cell damage induced by 
the toxin [18-20]. Further evidence for the involvement 
of a trimeric G-protein in the actions of InsP3 and thapsi- 
gargin comes from the results obtained with GDPflS and 
'caged' GTPyS. GDPflS inhibits the abilities of vaso- 
pressin [18] and thapsigargin (present results) to stimu- 
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late Ca 2÷ inflow, whereas GTPyS activates Ca 2+ inflow 
(in a pertussis toxin-sensitive manner) (present results 
and [18]). Since one of the characteristics of trimeric G 
proteins is activation by GTPyS and inhibition by 
GDPflS [25,26], the idea that a trimeric G protein is 
involved in store-operated Ca2+ inflow is consistent with 
these results. 
Since Gi2 and Gi3 are the only known pertussis toxin- 
sensitive trimeric G proteins in hepatocytes [28,29], it is 
likely that one of these proteins is the trimeric G-protein 
involved in store-operated Ca2÷ inflow. The requirement 
to treat hepatocytes with pertussis toxin for 36 h in order 
to inhibit InsP3-, thapsigargin- and DBHQ-stimulated 
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Fig. 2. The inhibition by pertussis toxin of GPIP2-stimulated and thapsigargln-stimulated Ca 2+ inflow. (a) The solid line is a representative trace 
obtained from a single hepatocyte from a rat treated with pertussis toxin, loaded with fluo-3 and 'caged' GPIP2 by microinjection, incubated initially 
in the absence of added Ca 2÷, exposed to UV light (arrow) and 1.3 mM Ca:o + (added at the beginning of the period indicated by the solid bar). The 
broken line represents a control experiment showing that GPIP2 stimulates Ca 2+ inflow in untreated (normal) hepatocytes. (b) The solid line is a 
representative trace obtained from a single hepatocyte from a rat treated with pertussis toxin, loaded with fluo-3, incubated in the absence of added 
Ca2o +and exposed to thapsigargin (10 gM in the extracellular medium) and 1.3 mM Ca 2+, added at the beginning of the periods indicated by the 
horizontal bars. The broken line represents a control experiment which shows that Ca 2÷ inflow was stimulated by thapsigargin i  an untreated (normal) 
hepatocyte. The results hown are those obtained for 15 of 20 cells tested and 8 of 11 cells tested for (a) and (b), respectively. 
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Fig. 3. The inhibition by GDPflS of thapsigargin-stimulated Ca 2÷ in- 
flow. The solid line is a representative trace obtained from a single 
untreated (normal) hepatocyte loaded with fura-2 and GDPflS 
(GDP[S]), incubated in the absence of added Ca2o ÷and treated with 
thapsigargin (10/zM in the extracellular medium) and 1.3 mM Ca2o ÷, 
added at the beginning of the periods indicated by the horizontal bars. 
The broken line represents a control experiment in which a single 
untreated (normal) hepatocyte was loaded with fura-2 and GMP, incu- 
bated in the absence of added Ca 2÷ then exposed to thapsigargin and 
Ca 2+. The results hown are those for 9 of 12 cells tested and 4 of 5 cells 
tested for hepatocytes loaded with GDPflS and GMP, respectively. 
Ca 2÷ inflow is consistent with the previous observation 
that, in hepatocytes, Gi~ subunits are ADP-ribosylated 
slowly [30]. 
Recently, evidence for the involvement of monomeric 
(low molecular weight) G-proteins, of the type which 
mediate membrane fusion, in store-operated Ca2÷ inflow 
in a mast cell line [15] and in lacrimal acinar cells [31] has 
been reported. (These G-proteins are inhibited by 
GTPyS [15,31] but, in the case of mast ceils, not by 
GDPflS [15].) The requirement for a monomeric G-pro- 
tein in store-operated Ca 2÷ inflow in hepatocytes i  not 
consistent with the present results (activation of Ca 2÷ 
inflow by GTPyS and inhibition of inflow by GDPflS). 
Moreover, it is not known whether the stimulation of 
Ca 2÷ inflow in mast cells and lacrimal acinar ceils is 
sensitive to pertussis toxin. Nevertheless, the possibility 
that a monomeric G-protein does work in conjunction 
with Giz/3 in activating plasma membrane Ca 2÷ inflow in 
the hepatocyte, but this action of a monomeric G-protein 
was not detected in the present experiments, cannot be 
excluded. 
It is presently considered that the sequence of events 
which leads from a G-protein-coupled receptor to activa- 
tion of the putative Ca 2÷ channel in the plasma mem- 
brane of hepatocytes is as follows. (i) The agonist binds 
to the receptor and activates phospholipase Cfl through 
the action of Oq/ll. (ii) This, in turn, increases InsP3 
which induces the release of Ca 2÷ from a region of the 
endoplasmic reticulum. (iii) Partial depletion of Ca 2÷ in 
the endoplasmic reticulum causes, through an unknown 
mechanism, opening of the putative Ca 2÷ channel. The 
observation that pertussis toxin inhibits thapsigargin-, 
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DBHQ- and InsP3-induced Ca 2+ inflow (present results) 
as well as agonist-stimulated Ca2+ inflow [18-20] pro- 
vides further evidence that this process of store-operated 
Ca 2+ inflow is the physiological mechanism by which 
G-protein-coupled receptors timulate Ca 2+ inflow in 
hepatocytes. It may be concluded from the present re- 
suits that the putative pertussis toxin-sensitive trimeric 
G protein Gi2~3 lies between the release of Ca 2÷ from the 
endoplasmic reticulum and activation of the putative 
Ca 2÷ channel. (Since pertussis toxin did not affect the 
ability of InsP3, thapsigargin or DBHQ to release Ca 2÷ 
from the endoplasmic reticulum, it is unlikely that Giz/3 
is required in this process.) 
G~u3 may be involved in the actions of recently-de- 
scribed putative intracellular messengers which have 
been proposed to link intracellular Ca 2÷ stores to the 
putative plasma membrane Ca 2÷ channel [13-15] and/or 
may allow association of the endoplasmic reticulum Ca 2÷ 
store with the plasma membrane [32]. The idea that a 
pertussis toxin-sensitive trimeric G-protein is a compo- 
nent of the mechanism of store-operated Ca 2÷ inflow in 
hepatocytes is consistent with mechanisms proposed for 
some other cell types in which a requirement for a pertus- 
sis toxin-sensitive trimeric G-protein in agonist-stimu- 
lated Ca 2÷ inflow has been reported [33,34], and the re- 
cent observation which implicates a trimeric G protein 
in store-operated Ca 2÷ inflow in granulocytes [35]. 
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